Pancreatic Cancer Biomarkers
Pancreatic cancer is the ninth leading cause of cancer diagnosis and fourth leading cause of cancer-associated death in the world. Pancreatic cancer biomarkers refer to cellular or biochemical mechanisms to aid in the detection, diagnosis, or prognostication of pancreatic cancer. Primarily, this term insinuates pancreatic exocrine tumors, specifically adenocarcinoma, but can be universally applied to all cancers arising within the pancreas. Additionally, the source and nature of pancreatic cancer biomarkers is not inherently defined and thus can denote any method to aid in its clinical detection or projection including but not limited to analysis of the proper tumor, tumor-surrounding tissues, implicated body secretions, and distant body fluids.
The term pancreatic cancer (PC) biomarkers can be contextually applied to many entities for multiple functions. In general terms, it refers to any biochemical detection mechanism that can be applied in PC to offer...
KeywordsPancreatic Cancer Chronic Pancreatitis Pancreatic Juice Main Pancreatic Duct Pancreatic Cancer Patient
- American Cancer Society (2009) Cancer facts and figures. American Cancer Society, AtlantaGoogle Scholar
- Surveillance Epidemiology and End Results Cancer Statistics Review 1975–2006 (2011) National Cancer Institute. Available at http://seer.cancer.gov/csr/1975_2006/index.html
- Weber C (2015) Biomarkers: the challenge to find biomarkers for the early detection of pancreatic cancer. Nat Rev Gastroenterol Hepatol. Epub ahead of printGoogle Scholar